Drug
Meropenem clinical trials
Also written Merrem and Meronem.
- studies test it
- 68
- open now
- 10
- in phase 3
- 18
- first study started
- 2001
Keep track of what changes. Save the Meropenem studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Brand
Studies by the year they started
68 studies that test it; most in 2012 (6)
| Year | Studies |
|---|---|
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 1 |
| 2004 | 2 |
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 5 |
| 2012 | 6 |
| 2013 | 4 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 4 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 5 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 5 |
| 2025 | 6 |
| 2026 | 4 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 11
- Phase 2
- 14
- Phase 3
- 18
- Phase 4
- 25
- No phase
- 8
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 17 · Other 51
Pfizer (4) · Antabio (3) · TASK Applied Science (3) · Qilu Pharmaceutical Co., Ltd. (3) · Hoffmann-La Roche (2) · Sutep Jaruratanasirikul (2) · PENTA Foundation (2) · Hellenic Institute for the Study of Sepsis (2)
Often tested with
Tested in the same studies.
Piperacillin, Tazobactam Drug Combination (7) · Ceftazidime (4) · Pilabactam sodium (3) · Pilabactam (3) · Cefepime (3) · Tigecycline (3) · Vancomycin (3) · Pralurbactam (3)
Studies
Open first, then newest update. How each study uses Meropenem is read from its arms, and is right about nine times in ten.
Testing it · 68
- THE ROLE OF PANCREATIC STONE PROTEIN (PSP) AND PSP-GUIDED EARLY MEROPENEM TREATMENT TO MITIGATE SEPSIS RISK AT THE EMERGENCY DEPARTMENT: THE PROMISE DOUBLE BLIND, PHASE III, RANDOMIZED CONTROLLED CLINICAL TRIALRecruitingPhase 3Hellenic Institute for the Study of SepsisNCT07813767Written as Meropenem Infusion
- The Vancomycin Piperacillin/Tazobactam (VPT) Patient Safety Trial (VPS)RecruitingPhase 4Bassett HealthcareNCT07556107Written as meropenem
- A Study to Assess How Vaborem® is Taking up in the Body and Tolerated in Paediatric Patients With Gram Negative Infections, Including But Not Restricted to Complicated Urinary Tract InfectionsRecruitingPhase 2Menarini GroupNCT06828848Written as Meropenem plus vaborbactam
- COMPARISON OF SINGLE VERSUS COMBINATION DRUG THERAPY IN EXTENSIVELY DRUG RESISTANT SALMONELLA TYPHI IN TERMS OF TIME TO DEFERVESCENCENot yet recruitingNot applicableIqra Asghar AliNCT07641348Written as meropenem
- A Study to Evaluate the Efficacy and Safety of Meropenem and Pralurbactam in HABP/VABPRecruitingPhase 3Qilu Pharmaceutical Co., Ltd.NCT07327619Written as Meropenem and Pralurbactam
- Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in Carbapenem-Resistant Enterobacteriaceae InfectionsRecruitingPhase 3Qilu Pharmaceutical Co., Ltd.NCT07089186Written as Meropenem and Pralurbactam
- Empirical Meropenem Versus Piperacillin/Tazobactam for Adult Patients With SepsisRecruitingPhase 4Scandinavian Critical Care Trials GroupNCT06184659Written as Meropenem
- Optimising TREATment for Severe Gram-Negative Bacterial InfectionsRecruitingPhase 4National University of SingaporeNCT07004049Written as Colistin/Polymyxin B + Meropenem
- A Pilot Study for Optimizing Meropenem Administration in the ICURecruitingNot applicableOslo University HospitalNCT05578586Written as Meropenem 1000 mg
- Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in CIAINot yet recruitingPhase 3Qilu Pharmaceutical Co., Ltd.NCT06633718Written as Meropenem and Pralurbactam
- Colistin and Meropenem Versus Amikacin and Meropenem for MDR Gram Negative Bacteria Regarding Efficacy and Safety.Active, not recruitingPhase 4Beni-Suef UniversityNCT07694700Written as Colistimethate sodium for injection, meropenem
- Comparison Between Carbapenems and Noncarbapenem Beta-lactam Antibiotics in Septic Burn PatientsActive, not recruitingPhase 1/2Ain Shams UniversityNCT07096310Written as Meropenem I.V. 2g as a 3 hour infusion every 8 hours
- Evaluation of the Concentration of ANT3310 and Meropenem in the Lung in Healthy Adult ParticipantsCompletedPhase 1AntabioNCT06916156Written as Meropenem
- EFFICACY OF PROLONGED INFUSION MEROPENEM IN CRITICALLY ILL PAEDIATRIC INTENSIVE CARE PATIENTSCompletedPhase 4Pakistan Navy Station Shifa HospitalNCT07122596Written as Meropenem Infusion
- Pharmacokinetics of Meropenem and Aztreonam After Intraperitoneal Administration Via Cycler-therapy in APD Patients Without PeritonitisCompletedPhase 2/3Karl Landsteiner Insitute for Nephrology and Haemato-OncologyNCT07113574Written as Meropenem 1000 mg
- Bolus Versus Continuous Infusion of MeropenemCompletedPhase 4Università Vita-Salute San RaffaeleNCT03452839Written as Meropenem
- Assessment of the Pharmacokinetics and Safety of ANT3310 Combined With Meropenem in Renally Impaired SubjectsCompletedPhase 1AntabioNCT06527677Written as Meropenem
- PK/PD of Extended-infusion Meropenem, Piperacillin-tazobactam and Cefepime in the Early Phase of Septic ShockCompletedPhase 3Centre Hospitalier Universitaire de BesanconNCT02820987Written as MEROPENEM
- Piperacillin/Tazobactam Versus Carbapenems in Non-bacteremic UTI Due to -ESBL-producing EnterobacteriaceaeSuspendedPhase 4Universidad del NorteNCT03891433Written as Meropenem
- Antimicrobial Revision in Persistent Febrile NeutropeniaWithdrawnPhase 4Wake Forest University Health SciencesNCT05784844Written as Meropenem
See all 68 studies that test Meropenem →
Given in every arm · 12 — Meropenem is usual care beside what is tested
- Study on the Safety and Efficacy of Polymyxin E2 Methanesulfonate for Injection in the Treatment of Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia Caused by Carbapenem-Resistant Gram-Negative BacteriaRecruitingPhase 2Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT07512596Written as Meropenem for injection
- A Clinical Trial for the Treatment of Carbapenem Resistant Gram-negative Bacterial Infection With Colistimethate Sodium for InjectionRecruitingPhase 3Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT06198764Written as Meropenem for Injection
- Fast-track Blood Test for Suspected Fever by Deficiency of a Kind of White Blood Cells As Main Defense Against InfectionRecruitingPhase 4The University of Hong KongNCT05393505Written as Meropenem Injection
- This Randomized Controlled Trial Evaluates the Comparative Efficacy of Intravenous Meropenem Alone Versus Intravenous Meropenem Combined With Oral Azithromycin in Children Aged 6 Months to Under 5 Years Diagnosed With Blood Culture-confirmed Extensively Drug-resistant Uncomplicated Typhoid FeverCompletedPhase 4Sheikh Zayed Medical CollegeNCT07445282Written as Meropenem
- Effect of Bronchoscopy on the Outcome of Patients With Severe Sepsis With ARDS and Complicated by VAP From Prolonged VentilationCompletedPhase 1/2King Abdul Aziz Specialist HospitalNCT06072222Written as Meropenem
- Effect of Bronchoscopy on the Outcome of Patients With Severe Sepsis With ARDS and Complicated by VAP From Prolonged VentilationCompletedPhase 1/2King Abdul Aziz Specialist HospitalNCT06072248Written as Meropenem
- Early Bactericidal Activity of Rifampin + Meropenem + Amoxicillin/Clavulanate in Adults With Pulmonary TBCompletedPhase 2Johns Hopkins UniversityNCT03174184Written as MEROPENEM 2 grams TID
- Effect of Bronchoscopy on the Outcome of Patients With Severe Sepsis With ARDS and Complicated by VAP From Prolonged VentilationCompletedPhase 1/2King Abdul Aziz Specialist HospitalNCT04553367Written as Meropenem
- Effect of Arterio-venous ECMO on Severe Sepsis and ARDSCompletedPhase 1/2Mohamed Gaber AllamNCT04555798Written as Meropenem Injection
- Safety, Tolerability, Pharmacokinetics of Intravenous FL058 and Meropenem in Healthy Subjects(SAD/MAD)CompletedPhase 1Qilu Pharmaceutical Co., Ltd.NCT05058105Written as Meropenem 1000 mg （ IV 120min）
- Comparison of Two Drugs Regimen in Treatment of Complicated Typhoid Fever in ChildrenCompletedPhase 4Ziauddin UniversityNCT04154722Written as Meropenem Injection
- A Study to Investigate the Intrapulmonary Lung Penetration of Nacubactam in Healthy ParticipantsCompletedPhase 1Hoffmann-La RocheNCT03182504Written as meropenem
As the comparator · 41 — what is tested is compared with Meropenem
- Ceftolozane/Tazobactam Versus Meropenem for Febrile Neutropenia on Patients Colonized With or at Risk for Infection With Extended Spectrum Beta Lactamase - Producing PathogensRecruitingPhase 4Beneficência Portuguesa de São PauloNCT06342115Written as Meropenem
- Meropenem vs Azithromycin Efficacy in Case XDR Enteric FeverRecruitingPhase 4Indus Hospital and Health NetworkNCT07314281Written as Meropenem Injection
- PipEracillin Tazobactam Versus mERoPENem for Treatment of Bloodstream Infections Caused by Cephalosporin-resistant Enterobacteriaceae (PETERPEN)RecruitingPhase 4Rambam Health Care CampusNCT03671967Written as Meropenem
- Cefiderocol and Ampicillin-sulbactam vs. Colistin +/- Meropenem for Carbapenem Resistant A. BaumanniiRecruitingPhase 4Rambam Health Care CampusNCT05922124Written as Meropenem
- Comparison of Efficacy and Safety of Ceftazidime Avibactam Versus Extended Infusions of High Dose Meropenem in Patients of ACLF With Nosocomial Infections.Not yet recruitingNot applicableInstitute of Liver and Biliary Sciences, IndiaNCT06818565Written as Meropenem Injection
- Study of Cefepime-tazobactam (FEP-TAZ) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)Not yet recruitingPhase 3WockhardtNCT03630081Written as Meropenem
- Piperacillin-tazobactam and Temocillin as Carbapenem-alternatives for the Treatment of Severe Infections Due to Extended-spectrum Beta-lactamase-Producing Gram-negative Enterobacteriaceae in the Intensive Care UnitRecruitingPhase 3Assistance Publique - Hôpitaux de ParisNCT05565222Written as Meropenem
- Evaluation of the Efficacy and Safety of Intravenous Imipenem/Cilastatin/XNW4107 in Comparison With Meropenem in Hospitalized Adults With cUTI Including AP (EudraCT no. 2022-000061-40)Not yet recruitingPhase 3Evopoint Biosciences Inc.NCT05204368Written as Meropenem
- A Trial of HRS-8427 in the Treatment of Adults With Bacterial PneumoniaCompletedPhase 2Jiangsu HengRui Medicine Co., Ltd.NCT06841731Written as Meropenem
- Study of Cefepime-zidebactam (FEP-ZID) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)CompletedPhase 3WockhardtNCT04979806Written as Meropenem
- PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONINCompletedPhase 2M.D. Anderson Cancer CenterNCT04983901Written as Meropenem
- Temocillin vs Meropenem for the Targeted Treatment of Bacteraemia Resistant to Third Gen CephalosporinsCompletedPhase 3Fundación Pública Andaluza para la gestión de la Investigación en SevillaNCT04478721Written as Meropenem
- PipEracillin/Tazobactam Versus mERoPENem for Treatment of AmpC Producing Blood Stream InfectionsWithdrawnPhase 4Rambam Health Care CampusNCT05355350Written as Meropenem
- Cefepime-taniborbactam vs Meropenem in Adults With VABP or Ventilated HABPWithdrawnPhase 3Venatorx Pharmaceuticals, Inc.NCT06168734Written as Meropenem
- Safety and Efficacy Study of Cefepime/VNRX-5133 in Patients With Complicated Urinary Tract InfectionsCompletedPhase 3Venatorx Pharmaceuticals, Inc.NCT03840148Written as Meropenem
- Trial of Meropenem Versus Piperacillin-Tazobactam on Mortality and Clinial ResponseCompletedPhase 4The University of QueenslandNCT02437045Written as Meropenem
- MK-7625A Versus Meropenem in Pediatric Participants With Complicated Urinary Tract Infection (cUTI) (MK-7625A-034)CompletedPhase 2Merck Sharp & Dohme LLCNCT03230838Written as Meropenem
- MK-7625A Plus Metronidazole Versus Meropenem in Pediatric Participants With Complicated Intra-Abdominal Infection (cIAI) (MK-7625A-035)CompletedPhase 2Merck Sharp & Dohme LLCNCT03217136Written as Meropenem
- Ceftolozane/Tazobactam (MK-7625A) Plus Metronidazole Versus Meropenem for Participants With Complicated Intra-abdominal Infection (MK-7625A-015)CompletedPhase 3Merck Sharp & Dohme LLCNCT03830333Written as Meropenem
- Ceftolozane-tazobactam Versus Meropenem for ESBL and AmpC-producing Enterobacterales Bloodstream InfectionWithdrawnPhase 3The University of QueenslandNCT04238390Written as Meropenem
Showing 20 of 41.
Codes
What other systems call Meropenem · ClinicalTrials.gg INT006796
- MeSH (NLM) D000077731MeropenemConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) FV9J3JU8B1MEROPENEMConfirmed FDA, NLM, Wikidata
- RxNorm 29561Confirmed FDA, Wikidata
- Wikidata Q47495774meropenem trihydrateConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C1160MeropenemConfirmed FDA, Wikidata
- DrugBank DBSALT002823One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000077731 | Meropenem | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | FV9J3JU8B1 | MEROPENEM | Confirmed FDA, NLM, Wikidata |
| RxNorm | 29561 | — | Confirmed FDA, Wikidata |
| Wikidata | Q47495774 | meropenem trihydrate | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C1160 | Meropenem | Confirmed FDA, Wikidata |
| DrugBank | DBSALT002823 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.